21 Oct 2009

Lynne is undergoing her second round of chemotherapy today. Her white count was at the low end of the normal range so tommorrow she is scheduled for a Neulasta shot to boost the white counte. She is more tired than normal but still doing fairly well under the circumstances. Her mobility and stability are compromised since discontinuing the steroid but we hope physical therapy will help that condition. We will cover this during her next neurologist appointment as well to seek additional options.

Regards,
Darryl Pendergrass
Motorola Q9h Global - FlexMail

6 Oct 2009

Lynne is working through the physical therapy and building her strength. She met with the oncologist and starts a chemotherapy regimen of Avastin and Irinotecan tomorrow. She will receive the treatments every two weeks until the next MRI scan to determine the effect on the tumor. The Avastin works by inhibiting the cancer cells’ ability to create or maintain vessels for their blood supply needed for continued growth. Avastin was FDA approved in May 2009 and according to some reports shows promise for recurrent Glioblastoma Muliforme brain tumors.

We appreciate your continued thoughts and prayers on our behalf. You can expect the frequency of blog posts to slow when things are somewhat stable.

Regards,

Darryl